In gastric cancer, METTL3, guided by an antisense lncRNA of ARHGAP5, ARHGAP5-AS1, methylates ARHGAP5 mRNA and promotes its stability to enhance cisplatin resistance [93]. The gene discussed is METTL3; the disease is gastric cancer.